Prostate Cancer Information

Teaching Hospitals With Fellowship Programs Have Less Radical Prostatectomy Complications Patients who undergo radical surgery for prostate cancer may expect better results, on average, if they're treated in accredited teaching hospitals with residency programs, and better still if the hospitals also have medical fellowships, according to a new study by Henry Ford Hospital...

Racial Disparities Revealed In Prostate Cancer Surgery Black prostate cancer patients may not be getting the same quality of care as white patients, according to a first-of-its-kind study by researchers at Henry Ford Hospital who found racial disparities in the results of surgery to remove diseased prostates...

Avoiding Repeat Biopsies In Prostate Cancer - MDxHealth Launches ConfirmMDx Each year, in the United States, more than 650,000 men receive a negative prostate biopsy result, with around 25-35% of these results being false negative. However, a new prostate cancer test has been launched by MdxHealth. The test - ConfirmMDx™ for Prostate Cancer - will help physicians identify which men have a true-negative prostate biopsy from those who may have occult cancer...

In Outcome Of Prostate Cancer Surgery, Higher Hospital Volume More Important Than Surgeon Experience Older, sicker, high-risk patients who undergo one of the most common treatments for prostate cancer get better results in larger, busier hospitals, according to new research by Henry Ford Hospital. In such cases, the same research showed the experience level of the surgeon doing the procedure mattered somewhat less than the hospital setting...

Biomarkers Discovered For Prostate Cancer Detection, Recurrence Alterations to the "on-off" switches of genes occur early in the development of prostate cancer and could be used as biomarkers to detect the disease months or even years earlier than current approaches, a Mayo Clinic study has found...

In Prostate Cancer, Genetic Abnormalities In Benign Or Malignant Tissues Predict Relapse While active monitoring of serum prostate specific antigen (PSA) levels in men over 50 has greatly improved early detection of prostate cancer, prediction of clinical outcomes after diagnosis remains a major challenge...

Younger And At-Risk Men Benefit From PSA Screening To Detect Prostate Cancer Screening younger men and men at risk of prostate cancer can be beneficial in reducing metastatic cancer and deaths and should not be abandoned, states an article published in CMAJ (Canadian Medical Association Journal)...

Ancient Remedy Slows Prostate Tumor Cell Proliferation An over-the-counter natural remedy derived from honeybee hives arrests the growth of prostate cancer cells and tumors in mice, according to a new paper from researchers at the University of Chicago Medicine. Caffeic acid phenethyl ester, or CAPE, is a compound isolated from honeybee hive propolis, the resin used by bees to patch up holes in hives...

Prostate Cancer Stem Cells Identified Among Low-PSA Cells Prostate cancer cells that defy treatment and display heightened tumor-generating capacity can be identified by levels of prostate specific antigen (PSA) expressed in the tumor cells, a research team led by scientists at The University of Texas MD Anderson Cancer Center reports in Cell Stem Cell...

Gay Men And Minorities Have Poorer Quality Of Life After Prostate Cancer Treatment To improve the quality of life in gay men and minorities treated for prostate cancer, a greater awareness of ethnic and sexual preference-related factors is needed to help men choose a more-suitable treatment plan, researchers from Thomas Jefferson University Hospital conclude in a literature review published in Nature Reviews Urology...

Boron-Nitride Nanotubes Show Potential In Cancer Treatment A new study has shown that adding boron-nitride nanotubes to the surface of cancer cells can double the effectiveness of Irreversible Electroporation, a minimally invasive treatment for soft tissue tumors in the liver, lung, prostate, head and neck, kidney and pancreas. Although this research is in the very early stages, it could one day lead to better therapies for cancer...

Cancer Survivors Told To Exercise, Eat Healthily, And Maintain Ideal Bodyweight If you are a cancer survivor and you want to minimize your risk of that cancer recurring, or another cancer developing, you should eat a healthy diet, do plenty of exercise, and maintain a healthy body weight, says the American Cancer Society in its new guidelines...

Denosumab (Xgeva) Not Approved For Metastasis Prevention Amgen's application for expanded indications for denosumab (Xgeva) were turned down by the FDA (Food and Drug Administration) - the expanded indications were to include bone metastases prevention in patients with castration-resistant prostate cancer...

Robot Assisted Prostate Cancer Surgery Associated With Fewer Complicated Outcomes A study published in the medical journal European Urology reveals that robot-assisted surgery to treat prostate cancer is more common and significantly more successful in the United States than radical "open" surgery...

The Aggressiveness Of Prostate Cancer Determined By New Diagnostic Tool One in six men will be diagnosed with prostate cancer during his lifetime, the second leading cause of death among men in the United States. It's a serious problem and current diagnostic tests aren't very specific...

Prostate Cancer Cells Destroyed By The Common Herb Oregano Oregano, the common pizza and pasta seasoning herb, has long been known to possess a variety of beneficial health effects, but a new study by researchers at Long Island University (LIU) indicates that an ingredient of this spice could potentially be used to treat prostate cancer, the second leading cause of cancer death in American men...

Robot-Assisted Prostate Cancer Surgery Leads To Fewer Complications, Better Outcomes Robot-assisted surgery is now both more common and far more successful than radical "open" surgery to treat prostate cancer in the United States, according to a new Henry Ford Hospital study published in the current issue of the medical journal European Urology...

Males With Mutated BRCA1 Breast Cancer Gene Have Higher Prostate Cancer Risk Men who carry the mutated BRCA1 gene have a four times greater chance of developing prostate cancer than other males, researchers from the Institute of Cancer Research and the Royal Marsden NHS Foundation Trust reported in the British Cancer Journal. The mutated BRCA1 is found in people with a family history of not only breast cancer, but ovarian cancer as well...

Prostate Cancer And Radiation Therapies - The Need For Additional Treatments In the April 18 issue of JAMA, a study comparing traditional radiation therapy to treat localized prostate cancer with intensity-modulated radiation therapy (IMRT) and proton therapy reveals thats IMRT was linked to fewer gastrointestinal side effects, receipt of additional cancer treatments and hip fractures but to more erectile dysfunction, whilst those who received proton ...

New Prostate Cancer Ultrasound Treatment Shows Promise A new experimental treatment for localized prostate cancer that uses high intensity focused ultrasound (HIFU) promises to be more effective and have fewer side effects than conventional treatments, according to a new study published early online in The Lancet Oncology on Tuesday...

Aggressive Prostate Cancer Risk Linked With Two Genetic Deletions In Human Genome According to a study published online in Proceedings of the National Academy of Sciences (PNAS), researchers have identified two inherited-genetic deletions in the human genome associated to the development of prostate cancer...

Personalizing Prostate Cancer Treatment Each year in the UK alone, about 37,000 men are diagnosed with prostate cancer. Given that prostate cancers can be genetically quite different, means they affect the way in which they react to treatments...

Link Between 2 Genetic Deletions In Human Genome And The Development Of Aggressive Prostate Cancer An international research team led by Weill Cornell Medical College investigators have discovered two inherited-genetic deletions in the human genome linked to development of aggressive prostate cancer...

New Policies Aimed At Controlling Costs Should Not Follow 'One Size Fits All' Approach In the current hyper-charged United States healthcare debate, the focus on lowering cost without compromising quality of care remains a priority. But according to a new study by researchers at NYU Langone Medical Center and colleagues, one common approach may have serious unintended consequences...